Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Recs

0
Player Avatar 80brown (96.99) Submitted: 5/2/2007 1:04:33 AM : Underperform Start Price: $27.92 REGN Score: -379.60

I valuate this one at 383% Intrinsic value.

Featured Broker Partners


Advertisement